Epidemiology of khat (Catha edulis) consumption among university students: a meta-analysis.
Epidemiology
Khat use
Meta-analysis
University students
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
04 Feb 2019
04 Feb 2019
Historique:
received:
05
02
2018
accepted:
29
01
2019
entrez:
6
2
2019
pubmed:
6
2
2019
medline:
1
5
2019
Statut:
epublish
Résumé
Khat is amphetamine-like substance commonly consumed by students when they wish to study for long hours especially during examination periods. Khat consumption is associated with increased rates of cardiovascular problems, stroke, myocardial infarction, cardiomyopathy, periodontal disease, gastritis, poor oral hygiene, psychosis, decreased quality of life, and poor academic performance. PubMed, EMBASE, and SCOPUS were systematically searched without restriction by publication status. Publications were screened according to predefined inclusion criteria. Twenty-five articles were included. Random effect model was used to calculate weighted prevalence, odds ratio (OR) and corresponding 95% confidence interval (CI). We assessed the risk of publication bias by using funnel plot and Eggers's regression tests. The pooled prevalence of current khat use among university students was 14.16% (95% CI; 11.87-16.81). The pooled prevalence of current khat use was highest in Saudi Arabia 18.85% and it was 13.59% in Ethiopia and 13.04% in Yemen. In addition, the current pooled prevalence of khat use was higher in men at 19.26% than in women 6.41%. Regarding lifetime khat use, in this study, the pooled prevalence of lifetime khat use was 27.31%. The lifetime prevalence was higher in men at 31.47% than in women 11.79%. Moreover, the lifetime prevalence of khat use was 43.27% in Yemen, 37.32% in Saudi Arabia, and 24.82% in Ethiopia. We found significantly increased odds of current (OR 3.59; 95%CI 2.01-6.41) as well as lifetime (OR 3.48; 95%CI 2.09-5.78) khat chewing in men as compared to women. The pooled prevalence of current and lifetime khat consumption was 14.16 and 27.31%, respectively. Both the current and lifetime prevalence of khat use was higher in men than in women. In addition, both the current and lifetime prevalence estimates of khat consumption were low in Ethiopia than in Saudi Arabia. Moreover, the odds of both current and lifetime khat consumption were higher in male students than in female students. Programmes that specifically aim at increasing awareness and that most motivate reduced khat consumption among university students were recommended.
Sections du résumé
BACKGROUND
BACKGROUND
Khat is amphetamine-like substance commonly consumed by students when they wish to study for long hours especially during examination periods. Khat consumption is associated with increased rates of cardiovascular problems, stroke, myocardial infarction, cardiomyopathy, periodontal disease, gastritis, poor oral hygiene, psychosis, decreased quality of life, and poor academic performance.
METHODS
METHODS
PubMed, EMBASE, and SCOPUS were systematically searched without restriction by publication status. Publications were screened according to predefined inclusion criteria. Twenty-five articles were included. Random effect model was used to calculate weighted prevalence, odds ratio (OR) and corresponding 95% confidence interval (CI). We assessed the risk of publication bias by using funnel plot and Eggers's regression tests.
RESULTS
RESULTS
The pooled prevalence of current khat use among university students was 14.16% (95% CI; 11.87-16.81). The pooled prevalence of current khat use was highest in Saudi Arabia 18.85% and it was 13.59% in Ethiopia and 13.04% in Yemen. In addition, the current pooled prevalence of khat use was higher in men at 19.26% than in women 6.41%. Regarding lifetime khat use, in this study, the pooled prevalence of lifetime khat use was 27.31%. The lifetime prevalence was higher in men at 31.47% than in women 11.79%. Moreover, the lifetime prevalence of khat use was 43.27% in Yemen, 37.32% in Saudi Arabia, and 24.82% in Ethiopia. We found significantly increased odds of current (OR 3.59; 95%CI 2.01-6.41) as well as lifetime (OR 3.48; 95%CI 2.09-5.78) khat chewing in men as compared to women.
CONCLUSION
CONCLUSIONS
The pooled prevalence of current and lifetime khat consumption was 14.16 and 27.31%, respectively. Both the current and lifetime prevalence of khat use was higher in men than in women. In addition, both the current and lifetime prevalence estimates of khat consumption were low in Ethiopia than in Saudi Arabia. Moreover, the odds of both current and lifetime khat consumption were higher in male students than in female students. Programmes that specifically aim at increasing awareness and that most motivate reduced khat consumption among university students were recommended.
Identifiants
pubmed: 30717743
doi: 10.1186/s12889-019-6495-9
pii: 10.1186/s12889-019-6495-9
pmc: PMC6360776
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
150Références
Phytother Res. 2002 Aug;16(5):403-13
pubmed: 12203257
Curr Neurol Neurosci Rep. 2003 Jan;3(1):40-5
pubmed: 12507409
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Clin Psychol Rev. 2003 Oct;23(5):719-59
pubmed: 12971907
Am Heart J. 1976 Jun;91(6):792-7
pubmed: 132114
Pharmacol Toxicol. 1992 Feb;70(2):77-86
pubmed: 1508843
East Afr Med J. 2004 Sep;81(9):468-73
pubmed: 15626057
BMC Public Health. 2005 Oct 14;5:109
pubmed: 16225665
Cerebrovasc Dis. 2006;22(2-3):198-200
pubmed: 16766870
Tijdschr Psychiatr. 2007;49(10):763-7
pubmed: 17929229
Drug Alcohol Depend. 2008 Jul 1;96(1-2):49-56
pubmed: 18353567
Subst Use Misuse. 2008;43(6):749-61
pubmed: 18473220
Prev Chronic Dis. 2008 Jul;5(3):A89
pubmed: 18558039
Harm Reduct J. 2009 Jun 20;6:11
pubmed: 19545389
Saudi J Kidney Dis Transpl. 2009 Sep;20(5):862-6
pubmed: 19736493
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
J Ethnopharmacol. 2010 Dec 1;132(3):564-9
pubmed: 20816745
J Ethnopharmacol. 2010 Dec 1;132(3):537-9
pubmed: 21115151
BMC Public Health. 2011 Aug 22;11:660
pubmed: 21859483
PLoS One. 2012;7(3):e33946
pubmed: 22479484
Ann Indian Acad Neurol. 2012 Apr;15(2):139-40
pubmed: 22566731
Br J Clin Pharmacol. 1990 Dec;30(6):825-8
pubmed: 2288828
J Family Community Med. 2009 Sep;16(3):89-95
pubmed: 23012198
Int J Dent. 2013;2013:317640
pubmed: 23509461
Biomed Res Int. 2013;2013:487232
pubmed: 23878809
BMC Public Health. 2013 Jul 30;13:693
pubmed: 23895376
Pan Afr Med J. 2013 Jul 11;15:95
pubmed: 24198889
J Res Med Sci. 2013 Aug;18(8):717-25
pubmed: 24379851
Trop Med Int Health. 2014 Apr;19(4):476-88
pubmed: 24479379
Health Qual Life Outcomes. 2014 Apr 04;12:44
pubmed: 24708622
J Addict. 2014;2014:969837
pubmed: 24872903
Harm Reduct J. 2014 Aug 09;11:21
pubmed: 25108629
Drug Alcohol Depend. 1989 Jan;23(1):19-29
pubmed: 2537717
BMC Public Health. 2014 Nov 21;14:1198
pubmed: 25416647
Subst Abuse Rehabil. 2015 Feb 26;6:41-50
pubmed: 25750551
Res Synth Methods. 2010 Apr;1(2):97-111
pubmed: 26061376
PLoS One. 2015 Jun 19;10(6):e0130460
pubmed: 26090658
PLoS One. 2015 Aug 06;10(8):e0134545
pubmed: 26247471
Int J Dent. 2015;2015:842096
pubmed: 26491448
J Res Health Sci. 2015 Fall;15(4):262-5
pubmed: 26728914
J Clin Diagn Res. 2015 Dec;9(12):ZC30-3
pubmed: 26813290
BMC Public Health. 2016 Feb 19;16:173
pubmed: 26895824
J Neurosci Rural Pract. 2016 Apr-Jun;7(2):200-5
pubmed: 27114648
J Neurosci Res. 2017 Jan 2;95(1-2):136-147
pubmed: 27870394
Afr Health Sci. 2016 Sep;16(3):822-830
pubmed: 27917217
BMC Psychiatry. 2017 Apr 17;17(1):142
pubmed: 28412950
J Clin Exp Dent. 2017 May 1;9(5):e629-e634
pubmed: 28512538
Psychiatry J. 2017;2017:7517450
pubmed: 28680879
BMC Res Notes. 2017 Sep 5;10(1):441
pubmed: 28870246
Gen Pharmacol. 1984;15(3):179-87
pubmed: 6376274
Clin Pharmacol Ther. 1994 May;55(5):556-62
pubmed: 7910126
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Br J Hosp Med. 1995 Oct 4-17;54(7):322-6
pubmed: 8556211
Ann Intern Med. 1976 Aug;85(2):246-9
pubmed: 942147